2.15. Safety analysis
hepatitis B-virus, TNF-α, human immunodeficiency virus, hepatitis C-virus
HUMAN IMMUNODEFICIENCY VIRUS
The participants underwent various biochemical and hematological tests before and after the intervention. Vital signs were monitored at all 4 visits, including blood pressure, respiratory rate, pulse rate, and physical examination. The routine laboratory parameters of safety, that is, hematology, lipid profile, serum biochemistry, human immunodeficiency virus, hepatitis B-virus, and hepatitis C-virus, 12-lead electrocardiogram, were measured using standard laboratory techniques at screening and final visits. The levels of hs-CRP, liver enzymes, and biomarkers (IL-10, and TNF-α) were measured at baseline and final visits by routine methods to ensure the safety of supplementation.